Susan M. O'Brien, MD

Susan M. O'Brien, MD

Specialties

Hematology/Oncology, Internal Medicine

MyChart patient portal offers a convenient and secure way to manage your healthcare online. Use MyChart to schedule appointments, request prescription renewals, send messages to your care team and more.
Medical Services
Certifications
  • American Board of Internal Medicine, Internal Medicine-General
  • American Board of Internal Medicine, Medical Oncology [Internal Medicine]
Language
  • English
Gender
Female
Medical School
University of Medicine and Dentistry of New JerseyMD Degree
Residency
University of Medicine & Dentistry of New JerseyInternal Medicine
Fellowship
The University of Texas MD Anderson Cancer CenterHematology/Oncology
Professional Positions
  • Professor — Division of Hematology/Oncology, Department of Medicine
  • Director — Sue and Ralph Stern Center for Cancer Clinical Trials and Research
  • Associate Director, Clinical Research — Chao Family Comprehensive Cancer Center
  • Past Chair — National Comprehensive Cancer Network guidelines panel for chronic myeloid leukemia
Awards and Recognition
  • Best Doctors in America® — Medical Oncology and Hematology, 2015, 2016
  • 2020 Giant of Cancer Care® — Leukemia
More Information

Dr. Susan M. O'Brien is a UCI Health hematology oncologist who specializes in hematology and medical oncology.

As associate director for clinical research at the UCI Health Chao Family Comprehensive Cancer Center, she oversees and coordinates clinical cancer research across the entire UCI Health enterprise, including medical oncology, radiation oncology, surgical oncology and gynecologic oncology.

Her clinical expertise is in the diagnosis and treatment of acute and chronic lymphocytic leukemia and she is actively involved in clinical trials as director of the UCI Health Sue and Ralph Stern Center for Cancer Clinical Trials and Research.

O’Brien earned her medical degree at the University of Medicine and Dentistry of New Jersey in Newark, N.J., where she also completed her residency in internal medicine, followed by a fellowship in Hematology/Oncology at University of Texas MD Anderson Cancer Center in Houston, Tex.

An internationally recognized leader in the research of treatments for both chronic and acute leukemias, she has developed several important therapies now regarded as the standard of care for chronic lymphocytic leukemia (CLL). She has served as the principal investigator for more than 40 funded clinical protocols and led the initial clinical research into ibrutinib (Imbruvica) for patients with chronic lymphocytic leukemia. She continues to research Bruton tyrosine kinase inhibitor in patients with CLL and small lymphocytic lymphoma.

O'Brien is the author of more than 900 articles in peer-reviewed journals, numerous book chapters and abstracts, she is also a past chair of the National Comprehensive Cancer Network guidelines panel on chronic myeloid leukemia. She was recently inducted into the 2020 Giants of Cancer Care® program by a panel of her peers in cancer research and clinical care.

She sees patients at the cancer center in Orange.

UCI Health Chao Family Comprehensive Cancer Center
101 The City Drive South, Building 23
Orange, CA 92868
Fax: 855-211-3729